BRIEF — Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan

Oct 5 (Reuters) — NeoGenomics, Inc.: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan Neogenomics, - Appoints Warren Stone As Ceo And Board Member Effective January 4, 2027 Neogenomics, - Tony Zook To Become Executive Chairman Effective January 4, 2027 Neogenomics, - Appoints Michael Kelly As Lead Independent Director Effective January 4, 2027 Neogenomics, - Preliminary Q3 Revenue Expected At $209 Million; Ngs Revenue Growth About 28% Neogenomics, - Full-year Total Revenue Guidance Expected To Increase At Midpoint Neogenomics: Current Chair Lynn Tetrault To Continue To Serve As Independent Director Until 2027 Annual Meeting And Not Stand For Reelection Then Source text:... Further company coverage: NEO.O (Reuters.Briefs@thomsonreuters.com;)